Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV. Date of publication 2009 Sep 1;volume 23(9):1008-17.
1. J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1008-17. doi: 10.1111/j.1468-3083.2009.03199.x. Epub 2009 Mar 11. Pyoderma gangrenosum: an updated review. Ruocco E(1), Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Author information: (1)Department of Dermatology, Second University of Naples, Naples, Italy. Pyoderma gangrenosum is a rare, ulcerative, cutaneous condition. First described in 1930, the pathogenesis of pyoderma gangrenosum remains unknown, but it is probably related to a hyperergic reaction. There are various clinical and histological variants of this disorder. Pyoderma gangrenosum often occurs in association with a systemic disease such as inflammatory bowel disease, rheumatologic disease, paraproteinaemia, or haematological malignancy. The diagnosis, mainly based on the clinical presentation and course, is confirmed through a process of elimination of other causes of cutaneous ulcers. Local treatment may be sufficient for mild disease, while for severe cases, systemic immunosuppressants are the mainstay. Long-term treatment with these agents is often required, but this can expose patients to adverse side-effects. DOI: 10.1111/j.1468-3083.2009.03199.x PMID: 19470075 [Indexed for MEDLINE]
Appears in following Topics:
Pyoderma Gangrenosum - Treatment
t
-->